Encompass Health Corporation
EHCHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeEncompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. At a $12.01B market cap, Encompass Health Corporation ranks as a large-cap company within healthcare. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Market Cap
$12.01B
Beta
0.61
P/E (TTM)
20.33
P/E (Fwd)
18.24
EPS (TTM)
$5.99
EPS (Fwd)
$6.68
ROE
25.0%
ROA
9.8%
Cash
$107.7M
Total Debt
$2.84B
Free CF
$229.9M
52W Change
-2.8%
Annual Financials
Cash vs Debt
Where EHC stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, EHC finished 12.82% above its 150-day moving average ($106.55) and 12.58% above its 200-day moving average ($106.78). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is EHC overbought or oversold?
At the September 1, 2026 close, EHC's RSI(14) was 25.5, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, EHC has $107.7M in cash with $2.84B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $229.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 25.0%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 9.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.35B (2022) to $5.94B (2025), reflecting a 36% increase over the period.
EHC's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Encompass Health Corporation and its sector.